Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency

Haemophilia ◽  
2015 ◽  
Vol 21 (3) ◽  
pp. 380-385 ◽  
Author(s):  
B. Brand-Staufer ◽  
M. Carcao ◽  
B. A. Kerlin ◽  
A. Will ◽  
M. Williams ◽  
...  
Haemophilia ◽  
2015 ◽  
Vol 22 (2) ◽  
pp. 268-275 ◽  
Author(s):  
K. Pénzes ◽  
C. Vezina ◽  
Z. Bereczky ◽  
É. Katona ◽  
M. Kun ◽  
...  

2003 ◽  
Vol 23 (1) ◽  
pp. 98-98 ◽  
Author(s):  
Flora Peyvandi ◽  
Liliana Tagliabue ◽  
Marzia Menegatti ◽  
Mehran Karimi ◽  
Istvan Komáromi ◽  
...  

2016 ◽  
Vol 14 (8) ◽  
pp. 1517-1520 ◽  
Author(s):  
K. Pénzes ◽  
K. Rázsó ◽  
É. Katona ◽  
A. Kerényi ◽  
M. Kun ◽  
...  

2009 ◽  
Vol 20 (7) ◽  
pp. 605-606 ◽  
Author(s):  
Pierre Morange ◽  
Nawel Trigui ◽  
Corinne Frère ◽  
Hervé Chambost ◽  
Catherine Pouymayou ◽  
...  

1974 ◽  
Vol 32 (01) ◽  
pp. 124-131 ◽  
Author(s):  
T Barbui ◽  
G Cartei ◽  
T Chisesi ◽  
E Dini

SummaryAntigenic material related to the fibrin stabilizing factor (Factor XIII-FSF) has been found in all the examined patients with congenital deficiency, albeit in reduced amount.Recently, Bohn et al. (1973) and Israels et al. (1973) showed that plasma Factor- XIII is composed by two subunits, A (or a) and S (or b); the former active protein, the latter probably FSF-binding protein.Using specific anti-S and anti-A antisera the Authors found, in a case of congenital deficiency of factor XIII, absence of subunit A. Subunit S presented abnormal behaviour as demonstrated by means of quantitative immunoelectrophoresis according to Laurell.


Haemophilia ◽  
2007 ◽  
Vol 13 (2) ◽  
pp. 221-222 ◽  
Author(s):  
N. TRIGUI ◽  
C. FRÈRE ◽  
C. D'ERCOLE ◽  
H. CHAMBOST ◽  
N. CHAPUIS ◽  
...  

2000 ◽  
Vol Volume 26 (Number 01) ◽  
pp. 005-010 ◽  
Author(s):  
Akitada Ichinose ◽  
Masayoshi Souri ◽  
Tomonori Izumi ◽  
Nobumasa Takahashi

Sign in / Sign up

Export Citation Format

Share Document